Educational Credits

This activity was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Interstate Postgraduate Medical Association and IMSVISUAL. The IPMA is accredited by the ACCME to provide continuing medical education for physicians.

The Interstate Postgraduate Medical Association designates this live activity for a maximum of 8* AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

If you require clarification of these statements, please contact the CE Office:

Interstate Postgraduate Medical Association (IPMA)
Heidi Ness, Director of Education & Accreditation
Email: hness@ipmameded.org
Phone: (608) 592‐1622

For information on how this activity fits in the Royal College Maintenance of Certification (MOC) Program, please visit the Royal College's website. For more personalized support, please contact the Royal College Services Centre (1-800-461-9598) or your local CPD Educator.

*Please note: This credit value is subject to change in the event of scheduling adjustments or content recommendations.

Disclosure Statements

As a provider dedicated to independent education and accredited by ACCME, IPMA must ensure balance, independence, objectivity, scientific rigor, and integrity in all its educational activities. All individuals with potential to influence the content of this program have disclosed all financial relationships that have occurred in the past 24 months with ineligible companies. The disclosures have been reviewed according to policy. All individuals with potential conflicts have been contacted as needed by IPMA staff and issues of conflict have been discussed, managed, and mitigated.

Please click here to review the disclosure reporting.

Additionally, all faculty have been asked to disclose to learners any discussion of off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States and investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.